We are monitoring the impact of COVID-19 & Recession alarm on MEA Safety Syringes Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Safety Syringes Market Research Report – Segmented By Technology, Therapy, End Users and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 311
Pages: 134

MEA Safety Syringes Market Size (2022 to 2027)

The size of the Safety Syringes Market in the Middle East & Africa was estimated at USD 491.83 million in 2022. It is predicted to grow and be worth USD 858.30 million by 2027, hiking at a CAGR of 11.78% from 2022 to 2027.

The primary role of the safety syringes is to protect healthcare providers against needlestick injuries. These are equipped with an integrated safety mechanism, which prevents injury and resultant complications. The increasing prevalence of diseases and the increasing incidence of needle sticks are the significant factors driving the growth of the MEA safety syringes market. According to the WHO, over 6.7 billion syringes are reused, where up to 72% of injections are given in the developing world. Many a time, as much as 70% of injections are unnecessary. Several countries have enacted laws for the mandatory use of safety syringes for the prevention of needlestick injuries. This initiative has led to the more common use of safety syringes. Advanced features like self-retracting needles and safety locking needles are gaining popularity among healthcare professionals due to ease of use and safety.

According to the WHO, over 4 million unintentional needle stick injuries were reported, with 38% of new hepatitis B cases in healthcare workers, 40% of new hepatitis C cases, and about 5.8% of new HIV cases. Of the global total of 35 million women and men living with HIV today, the vast majority (about 24 million or 70%) live in the sub-Saharan African region. Diabetic patients depend on a regular dose of insulin. Around 455 million people had diabetes globally in 2019. Therefore, this group of patients prefers safety syringes, ease of use, and high dosing accuracy. Rising healthcare expenditure and increased awareness of the benefits of safety syringes are also driving the safety syringes market in MEA.

However, the high cost of safety syringes, a lack of awareness in developing countries, and stringent local authority regulations are expected to hamper the growth of the MEA safety syringes market. In addition, the high incidence of trypanophobia is also the main challenge that may limit market growth. The preference for other modes of drug administration and the lack of awareness are the other factors that are estimated to have a negative impact on the studied market during the forecast period.

This research report on the Middle East and Africa Safety Syringes Market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Retractable Safety Syringes
  • Non-Retractable Safety Syringes

By Therapy: 

  • Insulin
  • GLP-1
  • Tuberculosis
  • Growth Hormones

By End Users: 

  • Hospitals
  • Home Care

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In 2020, the Middle East dominated the MEA market, and the trend is estimated to continue during the forecast period.

The regional market in UAE is analyzed to grow at a faster CAGR during the forecast period, owing to the increased awareness in the population for needle stick injuries, the high prevalence of HIV and blood-borne diseases, rapid adoption of technologies, and a developed market with advanced products and companies focusing on product launches. According to a recent study, over 70% of healthcare workers reported having a needle stick injury at least once during their clinical practice. Needlestick injuries were significantly higher in nurses at 77% and waste handlers at 70%.

In 2020, Saudi Arabia accounted for a significant share of the MEA safety syringe market. The market growth can be attributed to the increased focus on patient and healthcare provider safety, well-established healthcare infrastructure, new legislation designed to incorporate the practice of security and new products launched by market players, and the high number of needle stick injuries.

The African market is estimated to have a slow CAGR in the coming years due to poor healthcare facilities, lenient government authorities, and poor economic development in the years to come. However, the growing concerns about needlestick injuries will lead international companies to develop and market needles with improved safety features in this region.

KEY MARKET PLAYERS:

Companies that dominate the MEA safety syringes market profiled in this report are Covidien plc, Retractable Technologies Inc., Becton, Dickinson & Company, Terumo Unilife Corporation, Revolutions Medical Corporation, Smiths Medical, Sol-Millennium, Ultimed Inc., and Axel Bio Corporation.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Technology                                           

                                5.1.1 Retractable safety syringes                              

                                                5.1.1.1 Automatic retractable safety syringes     

                                                5.1.1.2 Manual retractable safety syringes           

                                5.1.2 Non-Retractable safety syringes                   

                                                5.1.2.1 Sheathing tube syringes                

                                                5.1.2.2 Sliding needle cover syringes      

                                                5.1.2.3 Hinged needle cover syringes     

                5.2 By Therapy                                 

                                5.2.1 Insulin                       

                                5.2.2 Glucagon-like peptide-1 (glp-1)                     

                                5.2.3 Tuberculosis                           

                                5.2.4 Growth hormones                               

                5.3 By End User                                

                                5.3.1 Hospitals                  

                                5.3.2 Home Care                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                6.2 Saudi Arabia                                               

                6.3 UAE                               

                6.4 Qatar                                             

                6.5 South Africa                               

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Becton, Dickinson & Company                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Covidien plc                                                

                8.3 Revolutions Medical Corporation                                      

                8.4 Retractable Technologies, Inc.                                           

                8.5 Smiths Medical                                         

                8.6 Unilife Corporation                                 

                8.7 Terumo Corporation                                               

                8.8 Sol-Millennum                                          

                8.9 Ultimed, Inc.                                              

                8.10 Axel Bio Corporation                                            

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

 

  1. Middle-East and Africa Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  2. Middle-East and Africa Safety Syringes Market, By Technology, From 2022 - 2027 (USD Million)
  3. Middle-East and Africa Retractable Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle-East and Africa Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  5. Middle-East and Africa Automatic retractable safety syringes Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle-East and Africa Manual retractable safety syringes Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle-East and Africa Non-Retractable Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle-East and Africa Non-Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  9. Middle-East and Africa Sliding Needle Cover Syringes Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle-East and Africa Hinged Needle Cover Syringes Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle-East and Africa Sheathing Tube Syringes Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle-East and Africa Safety Syringes Market, By Therapy, From 2022 - 2027 (USD Million)
  13. Middle-East and Africa Insulin Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle-East and Africa GLP-1 Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle-East and Africa Tuberculosis Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle-East and Africa Growth Hormones Safety Syringes Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle-East and Africa Safety Syringes Market, By End User, From 2022 - 2027 (USD Million)
  18. Middle-East and Africa Safety Syringes for Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle-East and Africa Safety Syringes for Home Care Market, By Region, From 2022 - 2027 (USD Million)
  20. Saudi Arabia Safety Syringes Market, By Technology, From 2022 - 2027 (USD Million)
  21. Saudi Arabia Safety Syringes Market, By Therapy, From 2022 - 2027 (USD Million)
  22. Saudi Arabia Safety Syringes Market, By End User, From 2022 - 2027 (USD Million)
  23. Saudi Arabia Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  24. Saudi Arabia Non-Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  25. UAE Safety Syringes Market, By Technology, From 2022 - 2027 (USD Million)
  26. UAE Safety Syringes Market, By Therapy, From 2022 - 2027 (USD Million)
  27. UAE Safety Syringes Market, By End User, From 2022 - 2027 (USD Million)
  28. UAE Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  29. UAE Non-Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  30. Qatar Safety Syringes Market, By Technology, From 2022 - 2027 (USD Million)
  31. Qatar Safety Syringes Market, By Therapy, From 2022 - 2027 (USD Million)
  32. Qatar Safety Syringes Market, By End User, From 2022 - 2027 (USD Million)
  33. Qatar Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  34. Qatar Non-Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  35. South Africa Safety Syringes Market, By Technology, From 2022 - 2027 (USD Million)
  36. South Africa Safety Syringes Market, By Therapy, From 2022 - 2027 (USD Million)
  37. South Africa Safety Syringes Market, By End User, From 2022 - 2027 (USD Million)
  38. South Africa Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)
  39. South Africa Non-Retractable Safety Syringes Market, By Type, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample